Autoimmune Hemolytic Anemia (AIHA) Treatment Cost in India
Autoimmune Hemolytic Anemias
Contact Us
Related Videos :
Frequently Asked Questions :
A: Warm AIHA involves antibodies that attack red blood cells at normal body temperature, often associated with autoimmune diseases. Cold AIHA involves antibodies that are more active in cooler temperatures, typically triggered by infections or cold exposure.
A: Management involves regular monitoring, adjusting immunosuppressive therapy, and avoiding triggers like certain medications or cold exposure. Long-term follow-up with a hematologist is essential for ongoing care.
Yes, if left untreated, AIHA can lead to severe anemia and complications. However, with proper treatment, most patients can achieve remission and lead normal lives.
Yes, treatments like splenectomy carry risks such as increased susceptibility to infections. Patients are often vaccinated against certain bacteria before undergoing this procedure.
Dr. Rahul Bhargava is a leading hematologist with extensive experience in treating AIHA. Patients benefit from his expertise in personalized treatment plans, access to state-of-the-art medical facilities, and the comprehensive care provided by his team. Additionally, the cost of treatment in India is significantly lower than in many Western countries, without compromising on the quality of care. India also offers a welcoming environment for international patients, ensuring a smooth and comfortable treatment journey.
Autoimmune Hemolytic Anemias :
If you or a loved one has been diagnosed with Autoimmune Hemolytic Anemia (AIHA), you’re in the right place. This page is designed to provide clear, in-depth, and trustworthy information about AIHA—what it is, what symptoms to look out for, how it’s diagnosed, the latest treatment options, expected costs, and answers to frequently asked questions.
With Dr. Rahul Bhargava’s expert guidance and personalized care approach, you’ll gain the understanding and support you need to navigate this condition confidently.
Understanding Autoimmune Hemolytic Anemias :
Autoimmune Hemolytic Anemia (AIHA) is a rare but serious condition where the immune system mistakenly attacks and destroys red blood cells. This destruction exceeds the bone marrow’s ability to produce new red blood cells, leading to anemia. AIHA can be classified into two main types based on the temperature at which the antibodies are most active:
- Warm Autoimmune Hemolytic Anemia: The antibodies attack red blood cells at normal body temperature.
- Cold Autoimmune Hemolytic Anemia: The antibodies are most active at cooler temperatures, often causing symptoms in response to cold exposure.
What Causes Autoimmune Hemolytic Anemia (AIHA)?
In many cases, the exact reason this happens isn’t fully understood—this is known as idiopathic AIHA. However, there are several known conditions and factors that can trigger or be associated with the development of AIHA:
🔹 Autoimmune Disorders
Sometimes, AIHA is linked to other autoimmune diseases, where the immune system turns against the body’s own tissues. Conditions like:
- Systemic lupus erythematosus (SLE)
- Rheumatoid arthritis can trigger AIHA as a secondary complication.
🔹 Infections
Certain viral or bacterial infections can confuse the immune system, prompting it to attack healthy red blood cells. Some of the more common infections linked to AIHA include:
- Epstein-Barr virus (EBV) – known for causing mononucleosis
- Cytomegalovirus (CMV)
- HIV or hepatitis in rare cases
🔹 Medications
Some drugs can alter red blood cells in a way that makes them appear foreign to the immune system. When this happens, the immune system attacks them, leading to hemolysis. Common culprits include:
- Penicillin and related antibiotics
- Methyldopa – a medication used for high blood pressure
- Quinidine – used for heart rhythm issues
🔹 Certain Cancers
AIHA may also occur in individuals with blood-related cancers or immune system malignancies, such as:
- Lymphoma – cancer of the lymphatic system
- Chronic lymphocytic leukemia (CLL) – a slow-growing type of blood cancer
Types of Autoimmune Hemolytic Anemia (AIHA) :
- Warm Autoimmune Hemolytic Anemia (Warm AIHA):
In this type, antibodies attack red blood cells at normal body temperature (around 37°C). It is the more common form of AIHA. - Cold Autoimmune Hemolytic Anemia (Cold AIHA):
In this type, antibodies become active and attack red blood cells at lower temperatures, typically below 30°C. This form is less common and symptoms often worsen with cold exposure.
- Warm Autoimmune Hemolytic Anemia (Warm AIHA):
Symptoms of Autoimmune Hemolytic Anemias :
- Fatigue and Weakness: Due to a reduced number of red blood cells.
- Shortness of Breath: Even with mild exertion.
- Pale or Yellow Skin (Jaundice): Resulting from the breakdown of red blood cells.
- Dark-Colored Urine: Due to hemoglobin released from destroyed red blood cells.
- Rapid Heartbeat: As the heart compensates for low oxygen levels.
- Dizziness or Lightheadedness: From decreased oxygen delivery to the brain.
- Enlarged Spleen or Liver: As these organs work to filter out damaged red blood cells.
Diagnosing Autoimmune Hemolytic Anemias :
Accurate diagnosis of AIHA involves several steps:
1. Medical History and Physical Examination
A thorough review of your medical history and a physical exam to identify signs of anemia, such as pale skin and an enlarged spleen or liver.
2. Blood Tests
- Complete Blood Count (CBC): To measure levels of red blood cells, hemoglobin, and hematocrit.
- Reticulocyte Count: To evaluate bone marrow function.
- Peripheral Blood Smear: To examine the shape and characteristics of red blood cells.
- Direct Antiglobulin Test (Coombs Test): To detect antibodies attached to red blood cells, confirming AIHA.
- Indirect Coombs Test: To detect free-floating antibodies in the blood.
3. Bone Marrow Examination
In some cases, a bone marrow biopsy may be performed to assess the production of blood cells and rule out other conditions.
Treatment Options for Autoimmune Hemolytic Anemias :
Dr. Rahul Bhargava provides comprehensive and personalized treatment plans for AIHA, focusing on the underlying cause and severity of the condition. Treatment options include:
1. Corticosteroids
Corticosteroids like prednisone are the first-line treatment to reduce immune system activity and decrease red blood cell destruction. The dosage and duration depend on the patient’s response.
2. Immunosuppressive Drugs
If corticosteroids are not effective, immunosuppressive drugs such as azathioprine or cyclophosphamide may be used to further suppress the immune system.
3. Intravenous Immunoglobulin (IVIG)
IVIG is administered to provide temporary relief by neutralizing the antibodies attacking red blood cells. This treatment is often used in acute cases or when rapid improvement is needed.
4. Blood Transfusions
In severe cases, blood transfusions may be necessary to quickly increase red blood cell count and alleviate symptoms. This is typically a short-term solution while other treatments take effect.
5. Plasmapheresis
Plasmapheresis is a procedure that filters the blood to remove harmful antibodies. It is usually reserved for severe cases or when other treatments have failed.
6. Splenectomy
For patients with refractory AIHA, a splenectomy (surgical removal of the spleen) may be considered. The spleen is responsible for filtering and destroying abnormal red blood cells, and its removal can reduce hemolysis.
Cost of Treatment and Stay in India :
India offers high-quality treatment for Autoimmune Hemolytic Anemia (AIHA) at affordable prices. Below is a summary of treatment costs in both INR and USD:
1.Consultation & Diagnosis
Consultation with Specialist: INR 2,000 – 3,000 | USD 25 – 40
Diagnostic Tests (CBC, Coombs Test, etc.): INR 5,000 – 15,000 | USD 60 – 180
Bone Marrow Biopsy (if required): INR 15,000 – 25,000 | USD 180 – 300
2. Treatment Costs
Corticosteroid Therapy (monthly): INR 5000 – 20,000 | USD 100 – 250
Immunosuppressive Drugs (monthly): INR 20,000 – 30,000 | USD 250 – 400
Intravenous Immunoglobulin (IVIG) per dose: INR 50,000 – 1,00,000 | USD 600 – 1,200
Blood Transfusion (per session): INR 5,000 – 10,000 | USD 60 – 120
Plasmapheresis (per session): INR 25,000 – 50,000 | USD 300 – 600
Splenectomy (Surgery): INR 4,50,000 – 6,00,000 | USD 5,000 – 7,000
3. Hospital Stay
General Ward (per day): INR 7,000 – 15,000 | USD 100 – 160
Private Room (per day): INR 12,000 – 16,000 | USD 150 – 200
4. Total Estimated Cost
For Mild to Moderate Cases: INR 1,00,000 – 3,00,000 | USD 1,200 – 3,600
For Severe Cases (with surgery/IVIG/Plasmapheresis): INR 3,00,000 – 6,00,000 | USD 3,600 – 7,200